Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

The hepatitis B vaccine is one of the very first vaccines your baby will get before she leaves the hospital. This vaccine protects her from a dangerous (but preventable!) liver infection and is given ...

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...

Dynavax reports record HEPLISAV-B revenue, 26% growth in 2024, and strong 2025 guidance. Insights on shingles vaccine progress & market expansion.

Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...

Reports Q4 revenue $73.0M, consensus $72.7M. “In 2024, we successfully executed on our strategic growth initiatives, achieving record ...

Deep Track, a Greenwich, Ct., investment management company that holds 13.5% of Dynavax's stock, pointed its finger at ...

After privately vying for a change to Dynavax’s corporate strategy for months, life sciences investment firm Deep Track ...